Lori Anne Kunkel, Director at Loxo Oncology, Inc. (LOXO), sold 32,392 shares at $182.35 ($5.8M) on 2018-06-14, disclosed to the SEC on 2018-06-18.
Open-market sale of $5.8M LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $180.28 | 28,440 | $5.1M | 87.7% |
| 2 | $181.48 | 2,411 | $438K | 7.5% |
| 3 | $182.35 | 1,541 | $281K | 4.8% |
| Total | $180.47 avg | 32,392 | $5.8M | 100% |
| Filing → |
| CRIS | SELL | 2019-01-25 | $16K | — | Filing → |
| LOXO | SELL | 2018-10-03 | $852K | — | Filing → |
| LOXO | SELL | 2018-06-18 | $1.2M | — | Filing → |